Nutrigenomics Market Report 2026

The nutrigenomics market size has grown rapidly in recent years. It will grow from $1.14 billion in 2025 to $1.35 billion in 2026 at a compound annual growth rate (CAGR) of 18.5%. The growth in the historic period can be attributed to limited awareness of nutrigenomics, dependence on general dietary guidelines, lack of access to genetic testing, high cost of genomic analysis, fragmented nutrition and healthcare data.

The nutrigenomics market size is expected to see rapid growth in the next few years. It will grow to $2.62 billion in 2030 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to growing adoption of personalized nutrition, advancements in dna sequencing and metabolomics, increasing integration of ai and big data in diet planning, rising awareness of preventive healthcare, expansion of nutrigenomic testing services across hospitals and clinics. Major trends in the forecast period include personalized diet planning based on genetic profile, integration of genomic data with nutrition apps, ai-powered nutrigenomic analysis, real-time health monitoring and feedback, predictive nutritional recommendations for disease prevention.

The rising health awareness among individuals is expected to drive the growth of the nutrigenomics market in the coming years. Health awareness encompasses understanding how lifestyle, diet, and genetics impact overall well-being, enabling individuals to prevent, manage, and treat various health conditions. As public interest in personalized health and nutrition grows, nutrigenomics - studying the interaction between genes and nutrients - empowers people to make dietary choices tailored to their genetic profile, optimize wellness, prevent chronic diseases, and support long-term health outcomes. For instance, in June 2024, according to the International Food Information Council (IFIC), a US-based non-profit organization, 54% of Americans followed a specific diet or eating pattern, with protein intake interest rising from 59% in 2022 to 71% in 2024, while approximately half of consumers prioritized fresh foods considered the healthiest options. Therefore, increasing health awareness is propelling the nutrigenomics market.

Major companies in the nutrigenomics market are focusing on technological innovations, such as personalized nutrition insights, to improve consumer health outcomes and deliver tailored dietary recommendations. Personalized nutrition insights provide guidance based on an individual’s genetic, biological, and lifestyle factors, enabling highly customized wellness strategies. For example, in June 2023, Xcode Life, a US-based genomics company, launched a gene nutrition test in India that analyzes nearly 50 aspects of nutrition. The test examines how genetic makeup affects metabolism, nutrient absorption, food sensitivities, and dietary responses, offering tailored recommendations to optimize health. The process includes a preliminary DNA test that streamlines genetic data collection and informs personalized dietary advice, leveraging nutrigenomic principles to connect gene expression with food impact.

In June 2024, Lifesum, a Sweden-based digital health company, acquired LYKON, a Germany-based nutrigenomics firm, for an undisclosed sum. Through this acquisition, Lifesum aims to enhance its digital health platform by integrating LYKON’s expertise in genetic-based nutrition and biomarker testing, creating a more comprehensive, science-driven approach to personalized wellness. This integration allows Lifesum to provide users with combined genetic insights and customized dietary recommendations to support improved health and overall well-being.

Major companies operating in the nutrigenomics market are Illumina Inc., Metagenics Inc., 23andMe, Genova Diagnostics Inc., Viome Inc., DNAfit, Nutrigenomix Inc., SelfDecode Inc., Fagron Genomics S L, XCODE Life Sciences Pvt Ltd, GenoPalate, 3X4 Genetics, Nutrigenomics Institute, Pathway Genomics, GeneFood, Helix, Mapmygenome, Nutrition Genome, DNALife, The Gene Box, GX Sciences, Genomelink, Vitagene.

North America was the largest region in the nutrigenomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nutrigenomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nutrigenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs on imported genetic testing kits, reagents, and sequencing equipment have impacted the nutrigenomics market by increasing costs for hospitals, clinics, and diagnostic service providers in north america, europe, and asia-pacific. These tariffs may temporarily slow adoption of advanced testing solutions but also encourage domestic production of nutrigenomic kits and local service providers, potentially creating more cost-effective options for personalized nutrition and preventive health applications.

The nutrigenomics market research report is one of a series of new reports that provides nutrigenomics market statistics, including nutrigenomics industry global market size, regional shares, competitors with a nutrigenomics market share, detailed nutrigenomics market segments, market trends and opportunities, and any further data you may need to thrive in the nutrigenomics industry. This nutrigenomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Nutrigenomics is the study of how genes and genetic variations affect an individual’s response to nutrients and diet. It seeks to understand the interaction between nutrition and the genome to optimize health and prevent disease. This field combines genetics, molecular biology, and nutrition science to create personalized dietary recommendations.

The main product types in nutrigenomics include reagents and kits, as well as services. Reagents and kits consist of the chemicals, compounds, and tools used for genetic testing and research in nutrition. Sample collection techniques include saliva, buccal swabs, and blood. Applications span areas such as diabetes, obesity, gastrointestinal health, women’s health, neurological conditions, and others. End users include hospitals, clinics, and additional healthcare and research facilities.

The nutrigenomics market includes revenues earned by entities by providing services such as genetic testing and analysis, personalized nutrition plans, consultation services, nutritional supplement development, and corporate wellness programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The nutrigenomics market also consists of sales of products including probiotics, protein and amino acid supplements, along with fortified foods and custom meal kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.